Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies - Textual (Details)

v3.20.1
Basis of Presentation and Summary of Significant Accounting Policies - Textual (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2020
USD ($)
reportingUnit
Mar. 31, 2020
USD ($)
segment
Dec. 31, 2019
USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Number of reporting units | reportingUnit 2    
Goodwill $ 3,241 $ 3,241 $ 3,241
Number of reportable segments 2 2  
Novel Biotherapeutics [Member]      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Goodwill, Allocated Percent 24.00% 24.00%  
Goodwill $ 800 $ 800  
Performance Enzymes [Member]      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Goodwill, Allocated Percent 76.00% 76.00%  
Goodwill $ 2,400 $ 2,400